A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study

NCT02658409 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1630

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GC3106(quadrivalent cell-culture based influenza vaccine)
BIOLOGICAL: Fluarix™tetra Syringe Inj.(quadrivalent influenza vaccine)

Sponsor

Green Cross Corporation